logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12636275 B1

PDFFull Text
Date of Patent:
May. 26, 2026

Filed:

Jan. 28, 2021

Pharmaceutical use of ketoamide-based compound

Applicant:

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, CN;

Inventors:

Hong Liu, Shanghai, CN;

Jian Li, Shanghai, CN;

Jingjing Peng, Shanghai, CN;

Xiong Xie, Shanghai, CN;

Wenhao Dai, Shanghai, CN;

Shulei Hu, Shanghai, CN;

Chunpu Li, Shanghai, CN;

Leike Zhang, Hubei, CN;

Zhenming Jin, Shanghai, CN;

Yechun Xu, Shanghai, CN;

Gengfu Xiao, Hubei, CN;

Haitao Yang, Shanghai, CN;

Fang Bai, Shanghai, CN;

XI Cheng, Shanghai, CN;

Hualiang Jiang, Shanghai, CN;

Kaixian Chen, Shanghai, CN;

Assignee:

SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, Shanghai, CN;

Attorney:

Panitch Schwarze Belisario & Nadel LLP

Primary Examiner:

Savitha M Rao

Int. Cl.
CPC ...
A61K 31/404 (2006.01); A61K 31/4025 (2006.01); A61K 31/4155 (2006.01); A61K 31/437 (2006.01); A61K 31/4412 (2006.01); A61K 31/443 (2006.01); A61K 31/4439 (2006.01); A61K 31/4525 (2006.01); A61K 31/453 (2006.01); A61K 31/4535 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/4709 (2006.01); A61K 31/498 (2006.01);
U.S. Cl.
CPC ...
A61K 31/404 (2013.01); A61K 31/4025 (2013.01); A61K 31/4155 (2013.01); A61K 31/437 (2013.01); A61K 31/4412 (2013.01); A61K 31/443 (2013.01); A61K 31/4439 (2013.01); A61K 31/4525 (2013.01); A61K 31/453 (2013.01); A61K 31/4535 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/4709 (2013.01); A61K 31/498 (2013.01);
Abstract

A class of ketoamide-based compounds, in particular, a ketoarnide-based compound as represented by general formula A is provided. The ketoamide compound may be used as a 2019 novel coronavirus (2019-nCov) 3 CL protease inhibitor and/or human cathepsin L inhibitor, and/or may be used in the preparation of a medicament for treating and/or preventing and relieving respiratory tract infection, pneumonia and other related diseases caused by 2019 novel coronavirus infection. Pharmaceutical compositions of the class of compounds, pharmaceutical salts, enantiomeric forms, diastereoisomers and racemic compounds thereof in the preparation of a medicament for treating and/or preventing and relieving respiratory tract infections and other related diseases caused by the 2019 novel coronavirus infection are also provided.

Find Patent Forward Citations

Liu, Hong. (2026). Pharmaceutical use of ketoamide-based compound (U.S. Patent No. 12636275). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12636275

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…